Osteoporosis is now recognized as a major threat to health in aging men. Morbidity and mortality, particularly following hip fracture, are substantial. Although trabecular bone loss starts in early adulthood, loss of cortical bone only seems to occur from midlife onwards. Declining bioavailable estradiol levels plays an integral role in male age-associated bone loss. Both pharmacologic and supportive care interventions are important for optimal care in men at an increased fracture risk.
|Number of pages
|Endocrinology and Metabolism Clinics of North America
|Published - Sep 2012
- Sex steroids
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism